# Filing Detail

Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001564590-21-027021
Filing Date
2021-05-12
Accepted
2021-05-12 16:21:41
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFR14A | acad-defr14a_20210622.htm | DEFR14A | 2579953
2 | GRAPHIC | ghlxznapjdgw000071.jpg | GRAPHIC | 544247
3 | GRAPHIC | ghlxznapjdgw000069.jpg | GRAPHIC | 13811
4 | GRAPHIC | ghlxznapjdgw000023.jpg | GRAPHIC | 214604
5 | GRAPHIC | ghlxznapjdgw000002.jpg | GRAPHIC | 11677
6 | GRAPHIC | ghlxznapjdgw000037.jpg | GRAPHIC | 241762
7 | GRAPHIC | ghlxznapjdgw000072.jpg | GRAPHIC | 409225
8 | GRAPHIC | ghlxznapjdgw000001.jpg | GRAPHIC | 5236
9 | GRAPHIC | ghlxznapjdgw000024.jpg | GRAPHIC | 57061
10 | GRAPHIC | ghlxznapjdgw000026.jpg | GRAPHIC | 158434
| Complete submission text file | 0001564590-21-027021.txt |  | 4860010

Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-50768 | Film No.: 21915432
SIC: 2834 Pharmaceutical Preparations